CSF2 and congenital rubella syndrome: Sterner et al. providee the first proof of concept that the neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF) abolishes toxicities (neuroinflammation and CRS) after CART-T cell therapy and may enhance their therapeutic activity.